Sign in
CompletedPhase 2

ASPirin in Immune thRombocytopenia Patients With Cardiovascular disEase

Key facts

Who runs it
University Hospital, Toulouse
Where
France1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 2
People taking part
4 people enrolled
Started
16 Jan 2023
Ended
2 Jan 2024
Type of study
Interventional
Treatments tested
  • Aspirin
Record updated
31 December 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • adult patients
  • non-treated immune thrombocytopenia or immune thrombocytopenia with stable treatment (at least 1 month)
  • treated with aspirin daily for a cardiovascular disease; stable platelet count < 100 x 109/L
  • at least one month following an arterial thrombosis
  • no other antiplatelet drug and anticoagulant
  • female patient with childbearing potential must have acceptable method of birth control
  • affiliated or benefiting from public health insurance

Who cannot take part

  • opposition to participate
  • adults under guardianship or other legal protection
  • deprived of their liberty by judicial or administrative decision
  • pregnancy or breastfeeding

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The incidence of immune thrombocytopenia increases with older age. This population is at risk for arterial thrombosis. Due to an increased turn-over of platelets, low-dose aspirin once daily may be insufficient in this population to protect against arterial thrombosis. This study is aimed at assessing the pharmacodynamics of aspirin once daily on platelet function in these patients.

The group in the trial

  • Single armTreatment being tested

    Sequential variations of daily aspirin intake time

    Treatment: Aspirin

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
31 December 2025